We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004025
Recruitment Status : Unknown
Verified July 2002 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : October 29, 2003
Last Update Posted : January 6, 2014
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given